Anti-glomerular basement membrane (anti-GBM) disease, historically referred to as Goodpasture’s disease, is a rare, aggressive autoimmune disorder that primarily targets the kidneys and ...

Anti-glomerular basement membrane (anti-GBM) antibodies were present in the patient's serum, and eosinophils were noted in his urine. Renal biopsy revealed active crescents, with linear staining ...

It is also known as anti-glomerular basement membrane disease (Anti-GBM disease), rapidly progressive glomerulonephritis with pulmonary hemorrhage, or pulmonary renal syndrome. The basement ...

Anti-glomerular basement membrane (anti-GBM) disease, also known as Goodpasture disease, is a rare, severe autoimmune condition affecting around 1.6 people per million annually with majority of ...

a global pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) disease. Anti-GBM is a rare, severe autoimmune condition affecting around 1.6 people per million annually.

Anti–glomerular basement membrane antibodies derive from an antigen-specific T-cell and B-cell response (T+B). The epitopes for the Goodpasture autoantibodies are inaccessible to anti ...

We describe two patients in whom anti–glomerular basement membrane disease developed after treatment with alemtuzumab.

Although resolution of the interstitial nephritis might have contributed to the patient's rapid return to normal renal function, the disappearance of anti-GBM antibodies and the long-sustained ...

Imlifidase is currently being studied in the following autoimmune diseases: anti-glomerular basement membrane (anti-GBM) disease and Guillain-Barré Syndrome (GBS). 1. Canney M ...